133 related articles for article (PubMed ID: 19318570)
1. A novel prostate cancer susceptibility locus at 19q13.
Hsu FC; Sun J; Wiklund F; Isaacs SD; Wiley KE; Purcell LD; Gao Z; Stattin P; Zhu Y; Kim ST; Zhang Z; Liu W; Chang BL; Walsh PC; Duggan D; Carpten JD; Isaacs WB; Grönberg H; Xu J; Zheng SL
Cancer Res; 2009 Apr; 69(7):2720-3. PubMed ID: 19318570
[TBL] [Abstract][Full Text] [Related]
2. A genome-wide survey over the ChIP-on-chip identified androgen receptor-binding genomic regions identifies a novel prostate cancer susceptibility locus at 12q13.13.
Feng J; Sun J; Kim ST; Lu Y; Wang Z; Zhang Z; Gronberg H; Isaacs WB; Zheng SL; Xu J
Cancer Epidemiol Biomarkers Prev; 2011 Nov; 20(11):2396-403. PubMed ID: 21960693
[TBL] [Abstract][Full Text] [Related]
3. Sequence variants at 22q13 are associated with prostate cancer risk.
Sun J; Zheng SL; Wiklund F; Isaacs SD; Li G; Wiley KE; Kim ST; Zhu Y; Zhang Z; Hsu FC; Turner AR; Stattin P; Liu W; Kim JW; Duggan D; Carpten J; Isaacs W; Grönberg H; Xu J; Chang BL
Cancer Res; 2009 Jan; 69(1):10-5. PubMed ID: 19117981
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide two-locus epistasis scans in prostate cancer using two European populations.
Tao S; Feng J; Webster T; Jin G; Hsu FC; Chen SH; Kim ST; Wang Z; Zhang Z; Zheng SL; Isaacs WB; Xu J; Sun J
Hum Genet; 2012 Jul; 131(7):1225-34. PubMed ID: 22367438
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide copy-number variation analysis identifies common genetic variants at 20p13 associated with aggressiveness of prostate cancer.
Jin G; Sun J; Liu W; Zhang Z; Chu LW; Kim ST; Sun J; Feng J; Duggan D; Carpten JD; Wiklund F; Grönberg H; Isaacs WB; Zheng SL; Xu J
Carcinogenesis; 2011 Jul; 32(7):1057-62. PubMed ID: 21551127
[TBL] [Abstract][Full Text] [Related]
6. Germ-line sequence variants of PTEN do not have an important role in hereditary and non-hereditary prostate cancer susceptibility.
Xie CC; Lu L; Sun J; Zheng SL; Isaacs WB; Gronberg H; Xu J
J Hum Genet; 2011 Jul; 56(7):496-502. PubMed ID: 21633361
[TBL] [Abstract][Full Text] [Related]
7. Cumulative effect of five genetic variants on prostate cancer risk in multiple study populations.
Sun J; Chang BL; Isaacs SD; Wiley KE; Wiklund F; Stattin P; Duggan D; Carpten JD; Trock BJ; Partin AW; Walsh PC; Grönberg H; Xu J; Isaacs WB; Zheng SL
Prostate; 2008 Sep; 68(12):1257-62. PubMed ID: 18491292
[TBL] [Abstract][Full Text] [Related]
8. Fine-mapping and family-based association analyses of prostate cancer risk variants at Xp11.
Lu L; Sun J; Isaacs SD; Wiley KE; Smith S; Pruett K; Zhu Y; Zhang Z; Wiklund F; Grönberg H; Walsh PC; Chang BL; Zheng SL; Isaacs WB; Xu J
Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2132-6. PubMed ID: 19549809
[TBL] [Abstract][Full Text] [Related]
9. Two independent prostate cancer risk-associated Loci at 11q13.
Zheng SL; Stevens VL; Wiklund F; Isaacs SD; Sun J; Smith S; Pruett K; Wiley KE; Kim ST; Zhu Y; Zhang Z; Hsu FC; Turner AR; Johansson JE; Liu W; Kim JW; Chang BL; Duggan D; Carpten J; Rodriguez C; Isaacs W; Grönberg H; Xu J
Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1815-20. PubMed ID: 19505914
[TBL] [Abstract][Full Text] [Related]
10. Fine mapping the KLK3 locus on chromosome 19q13.33 associated with prostate cancer susceptibility and PSA levels.
Parikh H; Wang Z; Pettigrew KA; Jia J; Daugherty S; Yeager M; Jacobs KB; Hutchinson A; Burdett L; Cullen M; Qi L; Boland J; Collins I; Albert TJ; Vatten LJ; Hveem K; Njølstad I; Cancel-Tassin G; Cussenot O; Valeri A; Virtamo J; Thun MJ; Feigelson HS; Diver WR; Chatterjee N; Thomas G; Albanes D; Chanock SJ; Hunter DJ; Hoover R; Hayes RB; Berndt SI; Sampson J; Amundadottir L
Hum Genet; 2011 Jun; 129(6):675-85. PubMed ID: 21318478
[TBL] [Abstract][Full Text] [Related]
11. Genetic variants at 1q32.1, 10q11.2 and 19q13.41 are associated with prostate-specific antigen for prostate cancer screening in two Korean population-based cohort studies.
Kim S; Shin C; Jee SH
Gene; 2015 Feb; 556(2):199-205. PubMed ID: 25434496
[TBL] [Abstract][Full Text] [Related]
12. Association of prostate cancer risk with SNPs in regions containing androgen receptor binding sites captured by ChIP-On-chip analyses.
Lu Y; Sun J; Kader AK; Kim ST; Kim JW; Liu W; Sun J; Lu D; Feng J; Zhu Y; Jin T; Zhang Z; Dimitrov L; Lowey J; Campbell K; Suh E; Duggan D; Carpten J; Trent JM; Gronberg H; Zheng SL; Isaacs WB; Xu J
Prostate; 2012 Mar; 72(4):376-85. PubMed ID: 21671247
[TBL] [Abstract][Full Text] [Related]
13. A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.
Tao S; Wang Z; Feng J; Hsu FC; Jin G; Kim ST; Zhang Z; Gronberg H; Zheng LS; Isaacs WB; Xu J; Sun J
Carcinogenesis; 2012 Mar; 33(3):598-603. PubMed ID: 22219177
[TBL] [Abstract][Full Text] [Related]
14. Association of a germ-line copy number variation at 2p24.3 and risk for aggressive prostate cancer.
Liu W; Sun J; Li G; Zhu Y; Zhang S; Kim ST; Sun J; Wiklund F; Wiley K; Isaacs SD; Stattin P; Xu J; Duggan D; Carpten JD; Isaacs WB; Grönberg H; Zheng SL; Chang BL
Cancer Res; 2009 Mar; 69(6):2176-9. PubMed ID: 19258504
[TBL] [Abstract][Full Text] [Related]
15. Pooled sample-based GWAS: a cost-effective alternative for identifying colorectal and prostate cancer risk variants in the Polish population.
Gaj P; Maryan N; Hennig EE; Ledwon JK; Paziewska A; Majewska A; Karczmarski J; Nesteruk M; Wolski J; Antoniewicz AA; Przytulski K; Rutkowski A; Teumer A; Homuth G; Starzyńska T; Regula J; Ostrowski J
PLoS One; 2012; 7(4):e35307. PubMed ID: 22532847
[TBL] [Abstract][Full Text] [Related]
16. Fine mapping association study and functional analysis implicate a SNP in MSMB at 10q11 as a causal variant for prostate cancer risk.
Chang BL; Cramer SD; Wiklund F; Isaacs SD; Stevens VL; Sun J; Smith S; Pruett K; Romero LM; Wiley KE; Kim ST; Zhu Y; Zhang Z; Hsu FC; Turner AR; Adolfsson J; Liu W; Kim JW; Duggan D; Carpten J; Zheng SL; Rodriguez C; Isaacs WB; Grönberg H; Xu J
Hum Mol Genet; 2009 Apr; 18(7):1368-75. PubMed ID: 19153072
[TBL] [Abstract][Full Text] [Related]
17. Fine mapping and functional analysis of a common variant in MSMB on chromosome 10q11.2 associated with prostate cancer susceptibility.
Lou H; Yeager M; Li H; Bosquet JG; Hayes RB; Orr N; Yu K; Hutchinson A; Jacobs KB; Kraft P; Wacholder S; Chatterjee N; Feigelson HS; Thun MJ; Diver WR; Albanes D; Virtamo J; Weinstein S; Ma J; Gaziano JM; Stampfer M; Schumacher FR; Giovannucci E; Cancel-Tassin G; Cussenot O; Valeri A; Andriole GL; Crawford ED; Anderson SK; Tucker M; Hoover RN; Fraumeni JF; Thomas G; Hunter DJ; Dean M; Chanock SJ
Proc Natl Acad Sci U S A; 2009 May; 106(19):7933-8. PubMed ID: 19383797
[TBL] [Abstract][Full Text] [Related]
18. Fine mapping of a region of chromosome 11q13 reveals multiple independent loci associated with risk of prostate cancer.
Chung CC; Ciampa J; Yeager M; Jacobs KB; Berndt SI; Hayes RB; Gonzalez-Bosquet J; Kraft P; Wacholder S; Orr N; Yu K; Hutchinson A; Boland J; Chen Q; Feigelson HS; Thun MJ; Diver WR; Albanes D; Virtamo J; Weinstein S; Schumacher FR; Cancel-Tassin G; Cussenot O; Valeri A; Andriole GL; Crawford ED; Haiman CA; Henderson BE; Kolonel L; Le Marchand L; Siddiq A; Riboli E; Key TJ; Kaaks R; Isaacs WB; Isaacs SD; Grönberg H; Wiklund F; Xu J; Vatten LJ; Hveem K; Njolstad I; Gerhard DS; Tucker M; Hoover RN; Fraumeni JF; Hunter DJ; Thomas G; Chatterjee N; Chanock SJ
Hum Mol Genet; 2011 Jul; 20(14):2869-78. PubMed ID: 21531787
[TBL] [Abstract][Full Text] [Related]
19. Individual and cumulative effect of prostate cancer risk-associated variants on clinicopathologic variables in 5,895 prostate cancer patients.
Kader AK; Sun J; Isaacs SD; Wiley KE; Yan G; Kim ST; Fedor H; DeMarzo AM; Epstein JI; Walsh PC; Partin AW; Trock B; Zheng SL; Xu J; Isaacs W
Prostate; 2009 Aug; 69(11):1195-205. PubMed ID: 19434657
[TBL] [Abstract][Full Text] [Related]
20. Large-scale fine mapping of the HNF1B locus and prostate cancer risk.
Berndt SI; Sampson J; Yeager M; Jacobs KB; Wang Z; Hutchinson A; Chung C; Orr N; Wacholder S; Chatterjee N; Yu K; Kraft P; Feigelson HS; Thun MJ; Diver WR; Albanes D; Virtamo J; Weinstein S; Schumacher FR; Cancel-Tassin G; Cussenot O; Valeri A; Andriole GL; Crawford ED; Haiman C; Henderson B; Kolonel L; Le Marchand L; Siddiq A; Riboli E; Travis RC; Kaaks R; Isaacs W; Isaacs S; Wiley KE; Gronberg H; Wiklund F; Stattin P; Xu J; Zheng SL; Sun J; Vatten LJ; Hveem K; Njølstad I; Gerhard DS; Tucker M; Hayes RB; Hoover RN; Fraumeni JF; Hunter DJ; Thomas G; Chanock SJ
Hum Mol Genet; 2011 Aug; 20(16):3322-9. PubMed ID: 21576123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
